Eagle Pharmaceuticals
EGRX
#9785
Rank
โ‚น0.98 B
Marketcap
โ‚น76.03
Share price
25.71%
Change (1 day)
-89.49%
Change (1 year)

Eagle Pharmaceuticals (EGRX) - Total liabilities

Total liabilities on the balance sheet as of June 2023 : โ‚น12.90 Billion

According to Eagle Pharmaceuticals 's latest financial reports the company's total liabilities are โ‚น12.90 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eagle Pharmaceuticals - Total liabilities on balance sheet (from 2013 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚น14.28 B148.31%
2021-12-31โ‚น5.75 B17.07%
2020-12-31โ‚น4.91 B-8.6%
2019-12-31โ‚น5.37 B-1.24%
2018-12-31โ‚น5.44 B-6.24%
2017-12-31โ‚น5.80 B35.39%
2016-12-31โ‚น4.28 B88.31%
2015-12-31โ‚น2.27 B
2014-09-30โ‚น1.25 B23.85%
2013-09-30โ‚น1.00 B-11.3%
2012-09-30โ‚น1.13 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น9.134 T 70,673.39%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.042 T 38,964.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น5.075 T 39,225.97%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น2.988 T 23,053.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
โ‚น7.041 T 54,458.78%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.177 T 40,013.50%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น6.460 T 49,951.71%๐Ÿ‡บ๐Ÿ‡ธ USA